India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

Harvey Jones thought he spotted the Diageo share price going cheap but jumped too soon. Could his bargain buy finally start ...

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Global consumption patterns are shifting and are driven by long-term changes in supply chains, pricing and consumer behaviour ...